Genomics for Clinical Testing
Excellence in quality and expertise. From extraction through to data, AGRF is your trusted partner in
world class clinical genomics.
With over 25 years of genomics expertise, AGRF is committed to delivering high quality, NATA accredited workflows for your clinical genomic applications. Our services are designed to provide fast turn around times and are offered at competitive pricing, ensuring you receive reliable and efficient genomic solutions.
Our Accreditation
AGRF provides innovative, robust, and reproducible clinical genomic services that meet NATA and NPAAC requirements. Our ISO15189 Human Pathology accreditation, built on a foundation of over 20 years of ISO/IEC 17025 compliance, ensures clinical-grade genomics services.
Learn more about our ISO15189 accreditation by viewing our NATA scope of accreditation.
Quick Guide for Clinical Testing: Drop down arrow to view
-
Panels and Targeted Sequencing
- TruSight® Oncology 500
- Twist Alliance clinical exome panel
- Twist V2 exome panel
-
Helpful resources to learn more about genomics for clinical applications.
How to work with AGRFGet in touch with one of our clinical experts
View our NATA scope of accreditation
-
Experienced provider of clinical genomics to major Australian Institutes, delivering high quality data rapidly and at competitive pricing.
Local laboratory and bioinformatic expertise available to discuss your project.
Data held securely in Australia.
Priority/urgent sample processing available.
-
The clinical utility of exome sequencing and extended bioinformatic analyses in adolescents and adults with a broad range of neurological phenotypes: An Australian perspective - LINK
Genome wide methylation profiling of selected matched soft tissue sarcomas identifies methylation changes in metastatic and recurrent disease - LINK
Pre-Vaccination Human Papillomavirus Genotypes and HPV16 Variants among Women Aged 25 Years or Less with Cervical Cancer - LINK
Mutations of the Sonic Hedgehog Pathway Underlie Hypothalamic Hamartoma with Gelastic Epilepsy. - LINK
Quantifying between-cohort and between-sex genetic heterogeneity in major depressive disorder. - LINK
Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis. - LINK
Assessment of a Polygenic Risk Score for Colorectal Cancer to Predict Risk of Lynch Syndrome Colorectal Cancer. - LINK
Client Testimonials
Contact your experienced clinical team today.
Your trusted partners. Excellence in quality and expertise.
Our team is always available to talk you through your next clinical project or any questions you might have - get in touch today to arrange a consultation.
Dr Mathi Appavoo
Clinical Genomics Specialist
M: +61 456 435 712
E: Mathi.Appavoo@agrf.org.au
Featured Blog Posts
